{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T03:50:03Z","timestamp":1773633003804,"version":"3.50.1"},"reference-count":20,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T00:00:00Z","timestamp":1499040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15J06295"],"award-info":[{"award-number":["15J06295"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15J06295"],"award-info":[{"award-number":["15J06295"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, for the Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"International Collaborative Research Program for Tackling the NTDs","award":["15jm0510001h0002"],"award-info":[{"award-number":["15jm0510001h0002"]}]},{"name":"the Japan Initiative for Global Research Network on Infectious Diseases","award":["15fm0108008h0001"],"award-info":[{"award-number":["15fm0108008h0001"]}]},{"name":"US-Japan Cooperative Medical Science Program","award":["15jk0210005h0027"],"award-info":[{"award-number":["15jk0210005h0027"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,7,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Quinolones are important antimicrobials for treatment of leprosy, a chronic infectious disease caused by Mycobacterium leprae. Although it is well known that mutations in DNA gyrase are responsible for quinolone resistance, the effect of those mutations on the enzymatic activity is yet to be studied in depth. Hence, we conducted in vitro assays to observe supercoiling reactions of wild type and mutated M. leprae DNA gyrases. DNA gyrase with amino acid substitution Ala91Val possessed the highest activity among the mutants. DNA gyrase with Gly89Cys showed the lowest level of activity despite being found in clinical strains, but it supercoiled DNA like the wild type does if applied at a sufficient concentration. In addition, patterns of time-dependent conversion from relaxed circular DNA into supercoiled DNA by DNA gyrases with clinically unreported Asp95Gly and Asp95Asn were observed to be distinct from those by the other DNA gyrases.<\/jats:p>","DOI":"10.1080\/09168451.2017.1314757","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T10:54:48Z","timestamp":1492512888000},"page":"1343-1347","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Quinolone resistance-associated amino acid substitutions affect enzymatic activity of <i>Mycobacterium leprae<\/i> DNA gyrase"],"prefix":"10.1080","volume":"81","author":[{"given":"Tomoyuki","family":"Yamaguchi","sequence":"first","affiliation":[{"name":"Division of Bioresources, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Central Research Laboratory, Kissei Pharmaceutical Co., Ltd, Azumino, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Division of Bioresources, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan"},{"name":"Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Bioresources, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan"},{"name":"Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,7,3]]},"reference":[{"key":"2021033109415786600_CIT0001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clindermatol.2015.10.016","article-title":"History of chemotherapy of leprosy","volume":"34","author":"Noordeen","year":"2016","journal-title":"Clin Dermatol"},{"key":"2021033109415786600_CIT0002","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1473-3099(11)70006-8","article-title":"Leprosy now: epidemiology, progress, challenges, and research gaps","volume":"11","author":"Rodrigues","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2021033109415786600_CIT0003","first-page":"389","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Global leprosy update, 2013; reducing disease burden"},{"key":"2021033109415786600_CIT0004","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2165\/00003495-199958002-00002","article-title":"Mode of action of fluoroquinolones","volume":"58","author":"Hooper","year":"1999","journal-title":"Drugs"},{"key":"2021033109415786600_CIT0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clindermatol.2014.07.007","article-title":"Treatment of leprosy","volume":"33","author":"Kar","year":"2015","journal-title":"Clin Dermatol"},{"key":"2021033109415786600_CIT0006","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1128\/AAC.01162-07","article-title":"Powerful bactericidal activity of moxifloxacin in human leprosy","volume":"52","author":"Pardillo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2021033109415786600_CIT0007","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/10409239109114072","article-title":"DNA gyrase: structure and function","volume":"26","author":"Reece","year":"1991","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2021033109415786600_CIT0008","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"2021033109415786600_CIT0009","doi-asserted-by":"crossref","first-page":"269","DOI":"10.47276\/lr.83.3.269","article-title":"Drug-resistant leprosy: monitoring and current status","volume":"83","author":"Williams","year":"2012","journal-title":"Lepr Rev"},{"key":"2021033109415786600_CIT0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7705\/biomedica.v34i0.1686","article-title":"Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment","volume":"34","author":"Guerrero","year":"2014","journal-title":"Biomedica"},{"key":"2021033109415786600_CIT0011","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1128\/AAC.45.12.3635-3639.2001","article-title":"Multidrug resistant mycobacterium leprae from patients with leprosy","volume":"45","author":"Maeda","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2021033109415786600_CIT0012","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/AAC.05890-11","article-title":"Amino Acid Substitutions at Position 95 in GyrA Can Add Fluoroquinolone Resistance to Mycobacterium leprae","volume":"56","author":"Yokoyama","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021033109415786600_CIT0013","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1128\/AAC.01550-10","article-title":"Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis","volume":"55","author":"Campbell","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021033109415786600_CIT0014","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1128\/AAC.00662-15","article-title":"Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis","volume":"59","author":"Willby","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2021033109415786600_CIT0015","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijantimicag.2007.10.014","article-title":"Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates","volume":"31","author":"Sun","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"2021033109415786600_CIT0016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.47276\/lr.81.2.137","article-title":"The history of Mycobacterium leprae Thai-53 strain","volume":"81","author":"Matsuoka","year":"2010","journal-title":"Lepr Rev"},{"key":"2021033109415786600_CIT0017","doi-asserted-by":"crossref","first-page":"e0005013","DOI":"10.1371\/journal.pntd.0005013","article-title":"DC-159a shows inhibitory activity against DNA gyrases of Mycobacterium leprae","volume":"10","author":"Yamaguchi","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2021033109415786600_CIT0018","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1128\/AAC.01282-06","article-title":"Expression and purification of an active form of the Mycobacterium leprae DNA Gyrase and its inhibition by quinolones","volume":"51","author":"Matrat","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2021033109415786600_CIT0019","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1128\/AAC.00042-11","article-title":"Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance","volume":"55","author":"Kim","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021033109415786600_CIT0020","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1128\/AAC.01095-07","article-title":"Are all the DNA gyrase mutations found in mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?","volume":"52","author":"Matrat","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Bioscience, Biotechnology, and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bbb\/article-pdf\/81\/7\/1343\/36823824\/bbb1343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bbb\/article-pdf\/81\/7\/1343\/36823824\/bbb1343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T11:52:00Z","timestamp":1654602720000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bbb\/article\/81\/7\/1343\/5954475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,3]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,3]]},"published-print":{"date-parts":[[2017,7,3]]}},"URL":"https:\/\/doi.org\/10.1080\/09168451.2017.1314757","relation":{},"ISSN":["0916-8451","1347-6947"],"issn-type":[{"value":"0916-8451","type":"print"},{"value":"1347-6947","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,3]]},"published":{"date-parts":[[2017,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tbbb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tbbb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-01-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}